Recent advances in understanding multiple sclerosis
Recent advances in understanding multiple sclerosis
https://f1000research.com/articles/8-2100
Abstract
Emerging data point to important contributions of both autoimmune inflammation and progressive degeneration in the pathophysiology of multiple sclerosis (MS).
Unfortunately, after decades of intensive investigation, the fundamental cause remains unknown. A large body of research on the immunobiology of MS has resulted in a variety of anti-inflammatory therapies that are highly effective at reducing brain inflammation and clinical/radiological relapses. However, despite potent suppression of inflammation, benefit in the more important and disabling progressive phase is extremely limited; thus, progressive MS has emerged as the greatest challenge for the MS research and clinical communities.
Data obtained over the years point to a complex interplay between environment (e.g., the near-absolute requirement of Epstein–Barr virus exposure), immunogenetics (strong associations with a large number of immune genes), and an ever more convincing role of an underlying degenerative process resulting in demyelination (in both white and grey matter regions), axonal and neuro-synaptic injury, and a persistent innate inflammatory response with a seemingly diminishing role of T cell–mediated autoimmunity as the disease progresses.
Together, these observations point toward a primary degenerative process, one whose cause remains unknown but one that entrains a nearly ubiquitous secondary autoimmune response, as a likely sequence of events underpinning this disease.
Here, we briefly review what is known about the potential pathophysiological mechanisms, focus on progressive MS, and discuss the two main hypotheses of MS pathogenesis that are the topic of vigorous debate in the field: whether primary autoimmunity or degeneration lies at the foundation. Unravelling this controversy will be critically important for developing effective new therapies for the most disabling later phases of this disease.
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 328 Views
-
Last post by Petr75
Sun Oct 18, 2020 6:20 am
-
- 1 Replies
- 930 Views
-
Last post by Petr75
Sat Nov 02, 2019 9:51 am
-
-
Exercise and the brain in multiple sclerosis
by NHE » Sat Nov 14, 2020 4:31 am » in Exercise and Physical Therapy - 0 Replies
- 309 Views
-
Last post by NHE
Sat Nov 14, 2020 4:31 am
-
-
- 0 Replies
- 408 Views
-
Last post by Petr75
Thu Dec 10, 2020 11:35 am
-
-
Biomarker: N-glucosylation in Multiple Sclerosis
by frodo » Tue Jul 21, 2020 1:54 am » in MS Etiology and Pathogenesis - 0 Replies
- 250 Views
-
Last post by frodo
Tue Jul 21, 2020 1:54 am
-
-
-
Type 1 diabetes (T1D) and multiple sclerosis
by Petr75 » Thu Jan 09, 2020 4:23 am » in General Discussion - 1 Replies
- 674 Views
-
Last post by frodo
Wed Jan 15, 2020 4:02 am
-
-
- 0 Replies
- 465 Views
-
Last post by Petr75
Thu Mar 19, 2020 10:24 am
-
-
Multiple Sclerosis and Ischemic Stroke
by Petr75 » Fri Mar 29, 2019 10:23 am » in General Discussion - 0 Replies
- 823 Views
-
Last post by Petr75
Fri Mar 29, 2019 10:23 am
-
-
-
A unified view of multiple sclerosis
by frodo » Sat Jan 30, 2021 3:48 am » in MS Etiology and Pathogenesis - 0 Replies
- 552 Views
-
Last post by frodo
Sat Jan 30, 2021 3:48 am
-